Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody. [electronic resource]
Producer: 19990729Description: 78-86 p. digitalISSN:- 0192-6233
- Animals
- Antibodies, Monoclonal -- adverse effects
- Drug Evaluation, Preclinical
- Endothelial Growth Factors -- immunology
- Humans
- Immunoglobulin G -- adverse effects
- Lymphokines -- immunology
- Neovascularization, Pathologic -- therapy
- Recombinant Proteins -- adverse effects
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.